These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38868725)

  • 1. Comprehensive review of multidimensional biomarkers in the ShangHai At Risk for Psychosis (SHARP) program for early psychosis identification.
    Zhang T; Xu L; Tang X; Wei Y; Hu Y; Cui H; Tang Y; Li C; Wang J
    PCN Rep; 2023 Dec; 2(4):e152. PubMed ID: 38868725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program.
    Zhang T; Xu L; Li H; Woodberry KA; Kline ER; Jiang J; Cui H; Tang Y; Tang X; Wei Y; Hui L; Lu Z; Cao L; Li C; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; Wang J
    Psychol Med; 2021 Mar; 51(4):653-660. PubMed ID: 31839016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis.
    Hamilton HK; Boos AK; Mathalon DH
    Biol Psychiatry; 2020 Aug; 88(4):294-303. PubMed ID: 32507388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Updates on Predicting Conversion in Youth at Clinical High Risk for Psychosis.
    Caballero N; Machiraju S; Diomino A; Kennedy L; Kadivar A; Cadenhead KS
    Curr Psychiatry Rep; 2023 Nov; 25(11):683-698. PubMed ID: 37755654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis.
    Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrión RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
    JAMA Psychiatry; 2022 Aug; 79(8):780-789. PubMed ID: 35675082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and Validation of Prediction Algorithms for Psychosis in Youths at Clinical High Risk.
    Worthington MA; Cao H; Cannon TD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Aug; 5(8):738-747. PubMed ID: 31902580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2).
    Wu G; Gan R; Li Z; Xu L; Tang X; Wei Y; Hu Y; Cui H; Li H; Tang Y; Hui L; Liu X; Li C; Wang J; Zhang T
    Neuropsychiatr Dis Treat; 2019; 15():3541-3548. PubMed ID: 31920314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
    Khoury R; Nasrallah HA
    Schizophr Res; 2018 Sep; 199():31-38. PubMed ID: 29703661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls.
    Hamilton HK; Roach BJ; Mathalon DH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Feb; 6(2):178-187. PubMed ID: 33431345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of Fluid Biomarker in Depressive Disorder.
    Serretti A
    Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):585-591. PubMed ID: 36263634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.
    Fusar-Poli P; Spencer T; De Micheli A; Curzi V; Nandha S; McGuire P
    Eur Neuropsychopharmacol; 2020 Oct; 39():111-122. PubMed ID: 32921544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma metabolic alterations and potential biomarkers in individuals at clinical high risk for psychosis.
    Li Z; Zhang T; Xu L; Wei Y; Cui H; Tang Y; Liu X; Qian Z; Zhang H; Liu P; Li C; Wang J
    Schizophr Res; 2022 Jan; 239():19-28. PubMed ID: 34800912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence.
    Mongan D; Föcking M; Healy C; Susai SR; Heurich M; Wynne K; Nelson B; McGorry PD; Amminger GP; Nordentoft M; Krebs MO; Riecher-Rössler A; Bressan RA; Barrantes-Vidal N; Borgwardt S; Ruhrmann S; Sachs G; Pantelis C; van der Gaag M; de Haan L; Valmaggia L; Pollak TA; Kempton MJ; Rutten BPF; Whelan R; Cannon M; Zammit S; Cagney G; Cotter DR; McGuire P;
    JAMA Psychiatry; 2021 Jan; 78(1):77-90. PubMed ID: 32857162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements and Future Directions in Prevention Based on Evaluation for Individuals With Clinical High Risk of Psychosis: Insights From the SHARP Study.
    Zhang T; Xu L; Wei Y; Cui H; Tang X; Hu Y; Tang Y; Wang Z; Liu H; Chen T; Li C; Wang J
    Schizophr Bull; 2024 May; ():. PubMed ID: 38741342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis.
    Heurich M; Föcking M; Mongan D; Cagney G; Cotter DR
    Mol Psychiatry; 2022 Jan; 27(1):127-140. PubMed ID: 34226666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm.
    Cadenhead KS; Duncan E; Addington J; Bearden C; Cannon TD; Cornblatt BA; Mathalon D; McGlashan TH; Perkins DO; Seidman LJ; Tsuang M; Walker EF; Woods SW; Bauchman P; Belger A; Carrión RE; Donkers F; Johannesen J; Light G; Niznikiewicz M; Nunag J; Roach B
    Front Psychiatry; 2020; 11():833. PubMed ID: 33005152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Electroencephalography Biomarkers in Individuals at Clinical High Risk for Psychosis in an International Multi-Site Study.
    Kerins S; Nottage J; Salazar de Pablo G; Kempton MJ; Tognin S; Niemann DH; de Haan L; van Amelsvoort T; Kwon JS; Nelson B; Mizrahi R; McGuire P; Fusar-Poli P;
    Front Psychiatry; 2022; 13():828376. PubMed ID: 35370849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.